Kevin Yates

Mr. Kevin Yates

University of California - Davis
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2021 in Critical Reviews in Biotechnology
Verified
Journal Article
Open access
MMMatthew J. McNulty
Matthew J. McNulty
YXYongao Xiong
Yongao Xiong
KYKevin Yates
Kevin Yates
KKKalimuthu Karuppanan
Kalimuthu Karuppanan
JHJacob M. Hilzinger
Jacob M. Hilzinger
Karen McDonaldKaren McDonald
Karen McDonald
Space missions have always assumed that the risk of spacecraft malfunction far outweighs the risk of human system failure. This assumption breaks down for longer duration exploration missions and exposes vulnerabilities in space medical systems. Space agencies can no longer reduce the majority of the human health and performance risks through crew members selection process and emergency re-supply or evacuation. No mature medical solutions exist to address this risk. With recent advances in biotechnology, there is promise for lessening this risk by augmenting a space pharmacy with a biologically-based space foundry for the on-demand manufacturing of high-value medical products. Here we review the challenges and opportunities of molecular pharming, the production of pharmaceuticals in plants, as the basis of a space medical foundry to close the risk gap in current space medical systems. Plants have long been considered to be an important life support object in space and can now also be viewed as programmable factories in space. Advances in molecular pharming-based space foundries will have widespread applications in promoting simple and accessible pharmaceutical manufacturing on Earth.

29 December 2020 in Preprints.org
Verified
Preprint
Open access
Aaron BerlinerAaron Berliner
Aaron Berliner
JHJacob M. Hilzinger
Jacob M. Hilzinger
AAAnthony J. Abel
Anthony J. Abel
MMMatthew McNulty
Matthew McNulty
GMGeorge Makrygiorgos
George Makrygiorgos
AAAdam P. Arkin
Adam P. Arkin
A crewed mission to and from Mars may include an exciting array of enabling biotechnologies that leverage inherent mass, power, and volume advantages over traditional abiotic approaches. In this perspective, we articulate the scientific and engineering goals and constraints, along with example systems, that guide the design of a surface biomanufactory. Extending past arguments for exploiting stand-alone elements of biology, we argue for an integrated biomanufacturing plant replete with modules for microbial \textit{in situ} resource utilization, production, and recycling of food, pharmaceuticals, and biomaterials required for sustaining future intrepid astronauts. We also discuss aspirational technology trends in each of these target areas in the context of human and robotic exploration missions in the coming century.

28 September 2024 in npj Microgravity
Verified
Journal Article
Open access
PDF file
KYKevin Yates
Kevin Yates
Aaron BerlinerAaron Berliner
Aaron Berliner
GMGeorgios Makrygiorgos
Georgios Makrygiorgos
FKFarrah Kaiyom
Farrah Kaiyom
MMMatthew J. McNulty
Matthew J. McNulty
Karen McDonaldKaren McDonald
Karen McDonald
Food production and pharmaceutical synthesis are posited as essential biotechnologies for facilitating human exploration beyond Earth. These technologies not only offer critical green space and food agency to astronauts but also promise to minimize mass and volume requirements through scalable, modular agriculture within closed-loop systems, offering an advantage over traditional bring-along strategies. Despite these benefits, the prevalent model for evaluating such systems exhibits significant limitations. It lacks comprehensive inventory and mass balance analyses for crop cultivation and life support, and fails to consider the complexities introduced by cultivating multiple crop varieties, which is crucial for enhancing food diversity and nutritional value. Here we expand space agriculture modeling to account for nitrogen dependence across an array of crops and demonstrate our model with experimental fitting of parameters. By adding nitrogen limitations, an extended model can account for potential interruptions in feedstock supply. Furthermore, sensitivity analysis was used to distill key consequential parameters that may be the focus of future experimental efforts.

27 December 2021 in Preprints.org
Verified
Preprint
Open access
Aaron BerlinerAaron Berliner
Aaron Berliner
ILIsaac Lipsky
Isaac Lipsky
DHDavian Ho
Davian Ho
JHJacob Hilzinger
Jacob Hilzinger
GVGretchen Vengerova
Gretchen Vengerova
AAAdam Arkin
Adam Arkin
Reinvigorated public interest in human space exploration has led to the need to address the science and engineering challenges described by NASA's Space Technology Grand Challenges (STGCs) for expanding the human presence in space. Here we define Space Bioprocess Engineering (SBE) as a multi-disciplinary approach to design, realize, and manage a biologically-driven space mission as it relates to addressing the STGCs for advancing technologies to support the nutritional, medical, and incidental material requirements that will sustain astronauts against the harsh conditions of interplanetary transit and habitation offworld. SBE combines synthetic biology and bioprocess engineering under extreme constraints to enable and sustain a biological presence in space. Here we argue that SBE is a critical strategic area enabling long-term human space exploration; specify the metrics and methods that guide SBE technology life-cycle and development; map an approach by which SBE technologies are matured on offworld testing platforms; and suggest a means to train the next generation spacefaring workforce on the SBE advantages and capabilities. In doing so, we outline aspects of the upcoming technical and policy hurdles to support space biomanufacturing and biotechnology. We outline a perspective marriage between space-based performance metrics and the synthetic biology Design-Build-Test-Learn cycle as they relate to advancing the readiness of SBE technologies. We call for a concerted effort to ensure the timely development of SBE to support long-term crewed missions using mission plans that are currently on the horizon.

5 March 2024 in Research Square
Verified
Preprint
Open access
PDF file
KYKevin Yates
Kevin Yates
Aaron BerlinerAaron Berliner
Aaron Berliner
GMGeorgios Makrygiorgos
Georgios Makrygiorgos
FKFarrah Kaiyom
Farrah Kaiyom
MMMatthew J. McNulty
Matthew J. McNulty
KMKaren A. McDonald
Karen A. McDonald
Food production and pharmaceutical synthesis are posited as essential biotechnologies for facilitating human exploration beyond Earth. These technologies not only offer critical green space and food agency to astronauts but also promise to minimize mass and volume requirements through scalable, modular agriculture within closed-loop systems, offering an advantage over traditional bring-along strategies. Despite these benefits, the prevalent model for evaluating such systems exhibits significant limitations. It lacks comprehensive inventory and mass balance analyses for crop cultivation and life support, and fails to consider the complexities introduced by cultivating multiple crop varieties, which is crucial for enhancing food diversity and nutritional value. Here we expand space agriculture modeling to account for nitrogen dependence across an array of crops and demonstrate our model with experimental fitting of parameters. By adding nitrogen limitations, an extended model can account for potential interruptions in feedstock supply. Furthermore, sensitivity analysis was used to distill key consequential parameters that may be the focus of future experimental efforts.